Théa and Nevakar sign an exclusive licensing agreement
Théa and Nevakar sign an exclusive licensing agreement for a unique therapeutic solution in the treatment of myopia progression in children.
Théa and Olix Pharmaceuticals sign a new partnership
Théa and Olix Pharmaceuticals sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
Théa and Curacle sign a new partnership
Théa Open Innovation and CURACLE sign a new partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics sign an exclusive licensing agreement
Théa and Coave Therapeutics announce their partnership
Leading a young company with a five-generation history
Listen to Jean-Frédéric's "fireside chat" recorded during the OIS meeting with Joseph Sullivan, Founder of Emmetropes, to discover: The progress of Théa Open Innovation that has made implementing licensing agreements and capital investments with early stage partners. The subsidiary has already signed agreements that help advance treatments for myopia,
Contact
N’hésitez pas à nous contacter pour nous soumettre vos idées et projets.